---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-21-109803"
form_type: "8-K"
ticker: "RPID"
cik: "0001380106"
company_name: "RAPID MICRO BIOSYSTEMS, INC."
filed_at: "2021-08-26T23:59:59+00:00"
generated_at: "2026-06-29T07:31:02.262073+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Rapid Micro Q2 commercial revenue $5.7M (+135% YoY); full-year outlook at least $24M

## Summary
- Q2 total revenue $6.1M vs $2.6M YoY; net loss ($11.8M) vs ($9.3M) YoY.
- Placed 8 new systems (cumulative 103); validated 11 systems (cumulative 63).
- Sold one-millionth consumable since Growth Direct commercial launch.
- Completed IPO in July 2021: ~9M shares sold, $165.3M net proceeds; pro forma cash ~$260M.
- Full-year 2021 commercial revenue guidance: at least $24.0M (≥70% YoY growth).

## SEC filing metadata
- accession: 0001104659-21-109803
- form_type: 8-K
- ticker: RPID
- cik: 0001380106
- company_name: RAPID MICRO BIOSYSTEMS, INC.
- filed_at: 2021-08-26T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1380106/000110465921109803/0001104659-21-109803-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1380106/000110465921109803/tm2125995d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-21-109803
- JSON: https://secwatch.observer/filing/0001104659-21-109803.json
- Plain text: https://secwatch.observer/filing/0001104659-21-109803.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.